CLINICAL_TRIALS
trial_result
· 2023-08-07
Clinical Trial Update: Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients [Phase 1, Phase 2]
Summary
Phase 1b/2a trial updates safety and efficacy of setmelanotide in overweight and obesity, with completed status and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rhythm Pharmaceuticals, Inc. | Conditions: Overweight and Obesity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-07